7bb), which often displayed the most intense GLP-1R immunolabeling (Figs
He continued to stand nearby watching quietly
Following the aforementioned incidents, the development of lotiglipron was discontinued, and drug regulatory agencies in several countries classified GLP-1RAs as a potential risk factor for thyroid cancer, gallbladder, and biliary diseases
To investigate the underlying mechanism, we conducted a proof-of-concept study using model cell lines
Zhang X, Belousoff MJ, Zhao P, Kooistra AJ, Truong TT, Ang SY, et al
Each session is customized to your health profile and performed by trained clinicians who prioritize safety, comfort, and patient care